SCHEMBL30516367

SCHEMBL30516367

CC(C)(C)OC(=O)N1CCN(c2cccc(NCc3cc(Cl)cc(Cl)c3)c2N)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
HTT P42858 1/20 0.46
ACHE P22303 2/20 0.46
STS P08842 4/20 0.45
MAPK8 P45983 1/20 0.44
SMARCA2 P51531 1/20 0.43
SMARCA4 P51532 1/20 0.43
PBRM1 Q86U86 1/20 0.43
MET P08581 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP2C19 P33261 1/20 0.41
BACE1 P56817 3/20 0.41
USP2 O75604 1/20 0.40
GLA P06280 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ADORA2A P29274 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21301974 1.00 SMN1; SMN2 (0.46) SMN1; SMN2NPSR1HTTACHESTS
SCHEMBL30516377 0.93 ACHE (0.47) SMN1; SMN2NPSR1HTTACHESTS
SCHEMBL21301932 0.93 ACHE (0.47) SMN1; SMN2NPSR1HTTACHESTS
SCHEMBL21301986 0.89 MAPK8 (0.47) SMN1; SMN2NPSR1HTTACHEMAPK8
SCHEMBL30516368 0.89 MAPK8 (0.47) SMN1; SMN2NPSR1HTTACHEMAPK8
SCHEMBL21301987 0.88 P2RX7 (0.46) SMN1; SMN2NPSR1HTTACHEMAPK8
SCHEMBL30516387 0.88 P2RX7 (0.46) SMN1; SMN2NPSR1HTTACHEMAPK8
SCHEMBL3853111 0.88 ACHE (0.58) SMN1; SMN2NPSR1HTTACHESTS
SCHEMBL31066764 0.88 ACHE (0.58) SMN1; SMN2NPSR1HTTACHESTS
SCHEMBL21302003 0.87 KCNQ2 (0.45) SMN1; SMN2NPSR1HTTACHEMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112041300-B Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists 阿达梅德制药公司 2023-07-28 CN disclosed